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INTRODUCTION
Previous clinical trials for the detection and treat-
ment of small pancreatic carcinoma have shown the
possibility of improved prognosis ; however, at the
time of diagnosis, only 10-11.6% of the patients can
be given a resection (1, 2). Moreover, in many cases,
despite the smallness of the primary lesion, livermetas-
tases were detected. Though the outcome of a patient
with liver metastases has not been satisfactory, some
recent studies have reported the possibility of im-
proved prognosis by modified chemotherapy. Among
them, arterial infusion chemotherapy has been reported
to be effective for the treatment of liver metastases
(3-5). This study reports a case of pancreatic carcin-
oma with multiple liver metastases that responded
well to transarterial infusion chemotherapy.
CASE REPORT
A 65-years-old male, diagnosed with multiple liver
tumors, visited our hospital. He was symptom-free,
and physical examination revealed no abdominal tumor
or signs of jaundice. Laboratory examinations showed
a slight elevation of liver function tests : asparate ami-
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notransferase (AST) ; 43 IU/L (normal range ; 10-35
IU/L), alanine aminotransferase (ALT) ; 50IU/L (nor-
mal range ; 15-40IU/L), alkaline phosphatase (ALP) ;
420 IU/L (normal range ; 81-231IU/L) and gamma-
glutamyl transpeptidase (gamma-GTP) ; 241 (normal
range ; <60IU/L). There were no elevations of tumor
markers : alpha fetoprotein (AFP), carbohydrate anti-
gen (CA) 19-9 and carcinoembryonic antigen (CEA).
Diagnostic images
An abdominal ultrasonography detected multiple
liver tumors, the largest being 8×8 cm in diameter.
A contrast enhanced computed tomography (CE-CT)
showed multiple low-density tumors in the liver (Fig.
1a), and a low-density mass 2 cm in diameter, in the
pancreatic head (Fig. 1 b). Endoscopic retrograde
cholangiopancreatography (ERCP) showed obstruc-
tion of the main pancreatic duct at the head of pancreas
(Fig. 2a). Endoscopic ultrasonography detcted a hy-
poechoic mass 3×2 cm in diameter in the pancreatic
head (Fig. 2b). Celiac angiography showed multiple
hypervascular tumors in the liver (Fig. 3).
Fig. 2a. ERCP showed obstruction of themain pancreatic duct
at the head of pancreas.
Fig. 1a. CE-CT showedmultiple low-density tumors in the liver. Fig. 2b. Endoscopic ultrasonography detected a hypoechoic
mass 3×2 cm in diameter in the pancreatic head.
Fig. 3. Celiac angiography showed multiple hypervascular
tumors in the liver.
Fig. 1b. CE-CT revealed a low-density mass 2cm in diameter
in the pancreatic head.
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US guided fine needle aspiration biopsy of the liver
tumor revealed adenocarcinoma, and then pancreatic
carcinomawithmultiple livermetastases was diagnosed.
Therapeutic regimen
A catheter was placed in the common hepatic artery
for arterial infusion chemotherapy via the right fem-
oral artery, and then the gastroduodenal artery and
right gastric artery were embolizedwith themicrocoils.
The catheter was connected to the port implanted in
the subcutaneous space of the right lower abdomen.
The patient received 5-fluorouracil (5-FU) and cisplatin
(CDDP) combination chemotherapy for 14 days (5-FU
at a dose of 500mg/day and CDDP of 10mg/day. Total
dose : 5-FU ;3500mg, CDDP;140mg). After 14days
administration, because of hepatic arterial occlusion,
the same dose of CDDP and 5-FU were administered
intravenously for 14 days until his discharge (Total
dose : 5-FU ; 3500mg, CDDP ; 140mg). At the same
time, the tumor in the pancreatic head was irradiated
with total 50 Grays (2 Grays/fraction per day).
Images after arterial infusion
After 14 days administration, CE-CT revealed a de-
crease of liver metastases in number and size (Fig.
4a), and a reduction in the size of the pancreatic tumor
(Fig. 4 b).
Clinical course after discharge
The patient was discharged from the hospital and
given chemotherapy intravenously 3 days aweek on an
outpatient basis. Although the chemotherapy was
effective, it was stopped because of severe general
fatigue 5 months after discharge. CE-CT showed no
sign of progression of liver and pancreatic tumors,
but ascites had appeared. His general status contin-
ued to gradually worsen ; however, he could remain
at home. The patient died 12 months after diagnosis
because of peritonitis carcinomatosa.
DISCUSSION
The prognosis and outcome of patients with pancre-
atic carcinoma still remain poor, despite various trials.
One of the major reasons for these unsatisfactory
results is its tendency to cause liver metastases. The
incidence of liver metastases from pancreatic carcin-
oma was 27.4% at diagnosis (2), and63% to78%at autopsy
(6). Moreover, in 50-62% of the patients after operations
or chemotherapies, liver metastasis was the reason
for therapeutic failure(2).
Recently, hepatic arterial infusion chemotherapy
was reported as an effective treatment for liver meta-
stases. Furuse et al. (4) treated liver metastases from
pancreatic carcinoma using hepatic arterial infusion
with 5-FU, and reported higher response rates than
venous infusion, but no improvement of survival (the
median survival time ; 15.9 weeks). Also, Suzuki et al.
(5) reported a case of percutaneous isolated hepatic
perfusion after local resection ; however, despite a
distinct regression of liver metastases, the patient
died 9 months after diagnosis. On the other hand,
Homma et al. (3) administered 5-FU and CDDP via a
catheter placed in the splenic and common hepatic
artery after hemodynamic change, and then themean
survival period was improved (16.25±8.35 months).
In our patient, although the primary pancreatic carcin-
oma was small in size and there was no evidence
of local invasion, metastatic liver tumors were very
large andmultiple. Then, livermetastaseswere regarded
as a prognostic factor, and hepatic arterial infusion
Fig. 4a. CE-CT revealed decrease of liver metastases in number
and size after 14 days administration.
Fig. 4b.Pancreatic tumorwas reduced after14days administration.
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chemotherapy with radiation was selected for the
primary pancreatic carcinoma. Liver tumorsdecreased
in number and size, and no progressionwas observed
throughout the follow-up period even after occlusion
of the hepatic artery. AlthoughFuruse et al. (4) pointed
out that hepatic arterial occlusion during arterial
chemotherapy would be responsible for the rapid pro-
gression of liver metastases, systemic chemotherapy
after arterial occlusion may contribute to the improve-
ment of the prognosis.
After discharge, the patient received systemic chem-
otherapy on an outpatient basis, and he could remain
at home without severe side effects. In conclusion,
transarterial infusion chemotherapy and subsequent
systemic chemotherapy may be effective for the treat-
ment of patients with pancreatic carcinoma with liver
metastases, and moreover, may improve the quality
of life of the patient.
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